Chou TY - Search Results

1

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.

Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Ferreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, Kris M, Jain D, Kim YT, Lopez-Rios F, Lu S, Mitsudomi T, Moreira A, Motoi N, Nicholson AG, Oliveira R, Papotti M, Pastorino U, Paz-Ares L, Pelosi G, Poleri C, Provencio M, Roden AC, Scagliotti G, Swisher SG, Thunnissen E, Tsao MS, Vansteenkiste J, Weder W, Yatabe Y. Travis WD, et al. Among authors: chou ty. J Thorac Oncol. 2020 May;15(5):709-740. doi: 10.1016/j.jtho.2020.01.005. Epub 2020 Jan 28. J Thorac Oncol. 2020. PMID: 32004713 Free PMC article. Review.

2

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.

Chou TY, Chiu CH, Li LH, Hsiao CY, Tzen CY, Chang KT, Chen YM, Perng RP, Tsai SF, Tsai CM. Chou TY, et al. Clin Cancer Res. 2005 May 15;11(10):3750-7. doi: 10.1158/1078-0432.CCR-04-1981. Clin Cancer Res. 2005. PMID: 15897572

3

Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.

Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC, Chen CY, Chen KC, Yang TY, Chou TY, Wang WH, Whang-Peng J, Shih NY. Chang GC, et al. Among authors: chou ty. Clin Cancer Res. 2006 Oct 1;12(19):5746-54. doi: 10.1158/1078-0432.CCR-06-0324. Clin Cancer Res. 2006. PMID: 17020980

4

Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer.

Wu YC, Su LJ, Wang HW, Jeff Lin CF, Hsu WH, Chou TY, Huang CY, Lu CL, Hsueh CT. Wu YC, et al. Among authors: chou ty. J Thorac Oncol. 2010 Aug;5(8):1167-74. doi: 10.1097/JTO.0b013e3181e2f4f5. J Thorac Oncol. 2010. PMID: 20592629 Free article.

5

A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy.

Chen YM, Fan WC, Tsai CM, Liu SH, Shih JF, Chou TY, Wu CH, Chou KT, Lee YC, Perng RP, Whang-Peng J. Chen YM, et al. Among authors: chou ty, chou kt. J Thorac Oncol. 2011 Jun;6(6):1110-6. doi: 10.1097/JTO.0b013e3182121c09. J Thorac Oncol. 2011. PMID: 21415778 Free article. Clinical Trial.

6

Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.

Hsu KH, Chen KC, Yang TY, Yeh YC, Chou TY, Chen HY, Tsai CR, Chen CY, Hsu CP, Hsia JY, Chuang CY, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Hsiung CA, Chang GC, Chen CJ, Yang PC. Hsu KH, et al. Among authors: chou ty. J Thorac Oncol. 2011 Jun;6(6):1066-72. doi: 10.1097/JTO.0b013e31821667b0. J Thorac Oncol. 2011. PMID: 21512404 Free article.

7

Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach.

Salto-Tellez M, Tsao MS, Shih JY, Thongprasert S, Lu S, Chang GC, Au JS, Chou TY, Lee JS, Shi YK, Radzi A, Kang JH, Kim SW, Tan SY, Yang JC. Salto-Tellez M, et al. Among authors: chou ty. J Thorac Oncol. 2011 Oct;6(10):1663-9. doi: 10.1097/JTO.0b013e318227816a. J Thorac Oncol. 2011. PMID: 21869714 Free article.

8

Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.

Chiu CH, Yeh YC, Lin KH, Wu YC, Lee YC, Chou TY, Tsai CM. Chiu CH, et al. Among authors: chou ty. J Thorac Oncol. 2011 Oct;6(10):1697-703. doi: 10.1097/JTO.0b013e318226b677. J Thorac Oncol. 2011. PMID: 21869716 Free article.

9

Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older.

Chen YM, Tsai CM, Fan WC, Shih JF, Liu SH, Wu CH, Chou TY, Lee YC, Perng RP, Whang-Peng J. Chen YM, et al. Among authors: chou ty. J Thorac Oncol. 2012 Feb;7(2):412-8. doi: 10.1097/JTO.0b013e31823a39e8. J Thorac Oncol. 2012. PMID: 22157367 Free article. Clinical Trial.

10

Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.

Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang BS, Wu YC. Hung JJ, et al. Among authors: chou ty. J Thorac Oncol. 2012 Jul;7(7):1115-23. doi: 10.1097/JTO.0b013e31824cbad8. J Thorac Oncol. 2012. PMID: 22592210 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page